Stryker ROE 2006-2018 | SYK

Current and historical return on equity (ROE) values for Stryker (SYK) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Stryker ROE for the three months ending September 30, 2018 was 28.00%.
Stryker ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $1.24B $9.86B 12.83%
2018-06-30 $1.08B $9.46B 11.05%
2018-03-31 $1.02B $9.22B 10.28%
2017-12-31 $1.02B $9.98B 10.16%
2017-09-30 $1.78B $10.43B 17.92%
2017-06-30 $1.70B $10.04B 17.61%
2017-03-31 $1.69B $9.70B 17.93%
2016-12-31 $1.65B $9.55B 17.91%
2016-09-30 $1.66B $9.33B 18.56%
2016-06-30 $1.61B $9.10B 18.39%
2016-03-31 $1.62B $8.81B 18.85%
2015-12-31 $1.44B $8.51B 17.02%
2015-09-30 $1.18B $8.48B 13.89%
2015-06-30 $0.93B $8.51B 10.96%
2015-03-31 $0.67B $8.32B 7.75%
2014-12-31 $0.52B $8.60B 5.84%
2014-09-30 $0.64B $8.62B 7.17%
2014-06-30 $0.69B $9.00B 7.67%
2014-03-31 $0.77B $9.06B 8.71%
2013-12-31 $1.01B $9.05B 11.55%
2013-09-30 $0.89B $8.74B 10.35%
2013-06-30 $1.14B $8.60B 13.41%
2013-03-31 $1.25B $8.46B 15.01%
2012-12-31 $1.30B $8.60B 15.77%
2012-09-30 $1.43B $8.36B 17.85%
2012-06-30 $1.40B $7.95B 17.98%
2012-03-31 $1.39B $8.02B 17.89%
2011-12-31 $1.35B $7.68B 17.66%
2011-09-30 $1.24B $7.56B 16.54%
2011-06-30 $1.25B $7.78B 16.82%
2011-03-31 $1.26B $7.45B 17.55%
2010-12-31 $1.27B $7.17B 18.25%
2010-09-30 $1.28B $7.31B 18.80%
2010-06-30 $1.18B $6.75B 17.78%
2010-03-31 $1.15B $6.67B 17.82%
2009-12-31 $1.11B $6.60B 17.91%
2009-09-30 $1.08B $6.44B 18.34%
2009-06-30 $1.12B $6.06B 19.69%
2009-03-31 $1.14B $5.63B 19.81%
2008-12-31 $1.15B $5.41B 19.72%
2008-09-30 $1.15B $5.75B 19.71%
2008-06-30 $1.10B $6.22B 19.43%
2008-03-31 $1.07B $5.93B 20.02%
2007-12-31 $1.02B $5.38B 20.54%
2007-09-30 $0.97B $5.16B 20.81%
2007-06-30 $0.93B $4.80B 21.27%
2007-03-31 $0.87B $4.49B 21.27%
2006-12-31 $0.78B $4.19B 20.16%
2006-09-30 $0.73B $3.99B 20.02%
2006-06-30 $0.66B $3.77B 19.34%
2006-03-31 $0.63B $3.49B 19.39%
2005-12-31 $0.64B $3.30B 20.94%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $64.420B $12.444B
Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.543B 19.40
Abbott Laboratories (ABT) United States $126.526B 25.64
Boston Scientific (BSX) United States $51.491B 26.02
Baxter (BAX) United States $35.393B 22.86
Zimmer Biomet Holdings (ZBH) United States $23.875B 15.48
Smith & Nephew SNATS (SNN) United Kingdom $16.038B 0.00
ResMed (RMD) United States $14.846B 28.31
Perrigo (PRGO) Ireland $8.596B 13.05
Bio-Rad Laboratories (BIO) United States $8.274B 52.91
Canopy Growth (CGC) Canada $8.174B 0.00
Hill-Rom Holdings (HRC) United States $6.270B 19.88
Aurora Cannabis (ACB) Canada $6.172B 33.68
Haemonetics (HAE) United States $5.727B 50.36
ICU Medical (ICUI) United States $4.968B 27.68
Insulet (PODD) United States $4.838B 0.00
Agios Pharmaceuticals (AGIO) United States $4.052B 0.00
Hutchison China MediTech (HCM) China $4.010B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.990B 0.00
Neogen (NEOG) United States $3.294B 49.88
NuVasive (NUVA) United States $3.166B 29.46
National Vision Holdings (EYE) United States $3.024B 58.49
Quidel (QDEL) United States $2.507B 32.68
Aphria (APHA) $2.433B 0.00
NxStage Medical (NXTM) United States $1.933B 0.00
Phibro Animal Health (PAHC) United States $1.409B 19.95
AtriCure (ATRC) United States $1.241B 0.00
Cardiovascular Systems (CSII) United States $1.058B 1524.50
VAREX IMAGING (VREX) United States $0.999B 20.07
Meridian Bioscience (VIVO) United States $0.823B 26.23
Surmodics (SRDX) United States $0.794B 121.41
OraSure Technologies (OSUR) United States $0.772B 43.48
Eagle Pharmaceuticals (EGRX) United States $0.755B 24.24
MacroGenics (MGNX) United States $0.740B 0.00
Cerus (CERS) United States $0.716B 0.00
PetIQ (PETQ) United States $0.705B 20.03
Lantheus Holdings (LNTH) United States $0.625B 19.35
Omeros (OMER) United States $0.619B 0.00
LeMaitre Vascular (LMAT) United States $0.540B 26.52
Owens & Minor (OMI) United States $0.535B 6.05
Insys Therapeutics (INSY) United States $0.527B 0.00
NanoString Technologies (NSTG) United States $0.521B 0.00
TG Therapeutics (TGTX) United States $0.444B 0.00
Evolus (EOLS) United States $0.403B 0.00
Quanterix (QTRX) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.332B 21.45
Cytosorbents (CTSO) United States $0.313B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.264B 0.00
Surface Oncology (SURF) United States $0.225B 0.00
Rockwell Medical (RMTI) United States $0.214B 0.00
BioLife Solutions (BLFS) United States $0.204B 275.00
Bovie Medical (BVX) United States $0.198B 0.00
Chimerix (CMRX) United States $0.172B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.146B 0.00
Fonar (FONR) United States $0.141B 7.06
Imprimis Pharmaceuticals (IMMY) United States $0.123B 0.00
Chembio Diagnostics (CEMI) United States $0.106B 0.00
United-Guardian (UG) United States $0.080B 16.85
Female Health (VERU) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 21.07
InfuSystems Holdings (INFU) United States $0.064B 0.00
CAS Medical Systems (CASM) United States $0.053B 0.00
Neurotrope (NTRP) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Capricor Therapeutics (CAPR) United States $0.028B 0.00
Myomo (MYO) United States $0.024B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Senestech (SNES) United States $0.017B 0.00
Akers Biosciences Inc (AKER) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00